So after yesterday does anyone believe a discounted share placement coming!. Revenue growing but cash pile reducing.
I’d say definitely a cash raise somewhere to fund expansion.
Cash is king |
CEO speaking to Proactive after the interim results: |
Proactive Investors:
Abingdon Health CEO discusses strong interim results, robust pipeline and growth strategy
Published: 10:38 15 Mar 2024 GMT
Yates said a 117% revenue increase to £2.4 million during the interim period was primarily driven by its CDMO division. This growth was attributed to increases in development, operational revenues, and the emergence of regulatory area revenues.
Despite an inflationary environment, Abingdon Health managed to maintain stable operating costs, resulting in improved gross margins to over 50%.
The company has a robust opportunity pipeline with 29 ongoing projects, emphasizing its fully integrated solution's appeal to customers. Yates also highlighted a good start to the second half of the year, with revenues expected to grow significantly while controlling costs to enhance operating profit performance. |
 York, U.K. 15th May 2024: Abingdon Health plc (AIM: ABDX), a leading international lateral flow Contract Development and Manufacturing Organisation (CDMO), announces the launch of Boots own-brand, saliva pregnancy self-test across the UK and online, in partnership with Salignostics and Crest Medical.
On 20th March 2024, Abingdon Health announced the launch of the first two Boots branded self-tests - Iron and Vitamin D deficiency - in-store and online at boots.com.
In another step toward strengthening this partnership with Boots, Abingdon Health is now pleased to announce the launch of the first ever saliva pregnancy test under the Boots own brand range. The test is being made available in store and online at boots.com from Spring 2024 onwards. This product launch allows more people to access a new way of testing for pregnancy.
With the UK pregnancy self-test market expected to reach USD $56.7 million by 20331, this provides a strategic opportunity to launch, on an own-brand basis, an innovative product in this growing market with the UK's leading health and beauty retailer. With general consumer adoption of self-tests on the rise (US $7.89 billion in 2023)2, and a robust pipeline of products within its CRO/CDMO offering, Abingdon Health is well positioned to continue developing OEM retail relationships within the UK and Europe as a value-add, innovative Private Label Supplier (PLS). |
!FOLLOWFEED
Launch of the Saliva Pregnancy self-test in Boots
Boots will be the first retailer to sell the world's first saliva pregnancy self-test under its own brand label
Tests will be available in Boots stores and online across the UK provided by Abingdon Health, Salignostics and Crest Medical partnership |
And were by chance called Bobdown1 before?. |
What's nice about it?, Bob. |
Nice to see abindon recovering from the tory debacle. Nice rns. |
Timbo
I thought the outlook statement was very misleading. Last year ABDX had a strong H2 weighting and it looks to be the same this year, so to say H2 will be materially ahead of H1 is meaningless. A comparison with H2 last year would have given investors a much better insight. Growth will not be 116% in H2 but I want to know
1. Will it be positive and
2. If positive, by roughly how much 20/30/40% etc.
Also, the cash outflow in H1 was £1.238m and they only have £2m cash left. While the burn rate will be lower in H2, without better guidance, it becomes impossible for private investors to make an informed view on the H2 outflow. No doubt Brokers will have been greater insight but it's not much help to me.
Based on the lack of clarity, I can't dismiss the need for another fund raise. |
Timbo,
I’ll join you tomorrow |
How times change!
* Confirmation today that no additional funding required
* Robust current trading
* top of the leader board today
* Last (very substantial) director purchases (at the last placing) were at level 2.5 X the current share price
and no comments? |
Note "without the need for additional funding" |
From today's statement: |
Recording from the Proactive event last week now available: |
A date for your diaries and a chance to meet the company management if you in or around the London area on January 11th: |
Switched to APH |
Register for the seminar mentioned in the previous post (which includes a presentation from ABDX) here: |
ShareSoc is holding its first hybrid event in London on 19th Oct. Hear from Abingdon Health (ABDX) and other healthcare companies like Tristel Plc (TSTL), Inspiration Healthcare Group (IHC), Creo Medical Group (CREO) and GENincode (GENI). Attend in-person or online.📍7760; Register: [...] |
Looks that way....
SalistickTM is the first rapid saliva-based pregnancy test with a new and improved user-experience, and high accuracy for early pregnancy detection. The kit is based on our revolutionary technology which detects the pregnancy hormone β-hCG in saliva. |
Is this the only one uk or global like it? |
 SaliStick test kit, received the CE mark from the European authorities and is currently working towards receiving FDA approval in the U.S.Saliva-based pregnancy test: 'Self-Testing Anywhere, by Anyone'"With SaliStick, a pregnancy test can be done anywhere and at any convenient time", says Salignostics."Saliva is the key to rapid diagnostics for a variety of medical reasons. It is the only non-invasive, easy, and hygienic means to detect hormones, viruses, and even diseases," adds Prof. Aaron Palmon, co-founder of Salignostics.This product completely removes the need for blood and urine samples when testing for pregnancy"With SaliStick, we leverage the powerful diagnostics abilities we have been able to create from analyzing saliva. This product completely removes the need for blood and urine samples when testing for pregnancy."Salignostics claims that the process is straightforward, easy to use and provides accurate results within a few minutes. It also boasts that the test can be done more conveniently and without needing a bathroom. |
Well certainly enjoyed reading back some of the trolls posts today.Guess they've retreated to their caves....Aw bless! |
Added to holding at this level. |
Caveat emptor |
Had to pay my road tax today. Long story short. So ventured into a smaller Superdrug outlet. No Salistick on display. The representative said that she knew of them and they were being supplied to the larger shops first and the smaller ones later. A recent delivery was awaiting shop distribution of latest delivery ...are we there?...
That's a distribution factor I suppose.
Anyways. Ongoing.
Spit or pee? That is the question!
And the price point is well within the parameters of the markets. One of the clear blue 29.99.
Check it out for yourself.
Even if you identify as a potato you can check out if you are impregnated by a mouth swab as opposed to a urinal splatter test. |
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
